Viking Global’s Top 5 Stocks

Page 5 of 5

1. Ginkgo Bioworks Holdings, Inc. (NYSE:DNA)

Percentage of Viking Global’s 13F Portfolio: 9.74%

Viking Global’s Stake Value: $3,511,109,000

Number of Hedge Fund Holders: 32

Cell engineering company Ginkgo Bioworks Holdings, Inc. (NYSE:DNA) is the biggest holding in Viking Global’s portfolio as of Q3 2021. The Boston-based biotech firm focuses on developing cell programming platforms that are utilized in manufacturing applications from cheesemaking to pharmaceuticals. Ginkgo Bioworks Holdings, Inc. (NYSE:DNA) also provides COVID-19 monitoring services, with over 3 million tests accomplished in the second half of 2021.

Ginkgo Bioworks Holdings, Inc. (NYSE:DNA) purchased Project Beacon COVID-19 LLC, a COVID-19 testing provider, in January to reinforce its expanding biosecurity platform and provide broader COVID-19 testing options in Massachusetts.

Viking Global initiated its position in Ginkgo Bioworks Holdings, Inc. (NYSE:DNA) in Q3 2021 and purchased over 302 million shares worth more than $3.5 billion. The company represents 9.74% of Viking Global’s 13F holdings at the end of September 2021. 

Moreover, 32 hedge funds were bullish on Ginkgo Bioworks Holdings, Inc. (NYSE:DNA) at the end of the third quarter of 2021.

You can also take a look at the Top 10 Stock Picks of Travis Cocke’s Voss Capital and 15 Blue Chip Dividend Stocks With Over 4% Yield.

Page 5 of 5